EC
EMBC
HealthcareEmbecta Corp.
Price Chart
Loading...
Market Data
Revenue TTMXBRL
—
Net IncomeXBRL
—
Gross MarginXBRL
—
EPS (Diluted)XBRL
—
No analysis generated yet. Run the pipeline for this company.
AI-extracted key facts from press releases and SEC filings. Significance 1–10.
7
M&ANeutralPer-CompanyMar 23, 2026
Embecta to acquire Owen Mumford for $199.4M to expand drug-delivery portfolio
- ▸Acquisition valued at up to $199.4M (£150M)
- ▸$133M upfront payment with $66.4M tied to Aidaptus sales performance
- ▸Transaction expected to close in fiscal Q3 2026
- ▸Deal adds Aidaptus auto-injector platform to chronic care portfolio
- ▸Strategic shift to expand beyond diabetes into broader medical supplies